We know that typically people will regain weight when they come off GLP-1 drugs for an extended period, Adeyemo says
(It appears to be a fragment of a larger gastric protein, but no one has traced it to a human gene
However, despite their significant quality of life improvements, they can be accompanied by significant gastrointestinal side effects, including nausea, vomiting, abdominal pain, diarrhea, fatigue, and weight loss 16
After propensity score matching against multiple antidiabetic drug classes (insulin, metformin, SGLT-2 inhibitors, DPP-4 inhibitors, sulfonylureas), results showed: No significant increase in thyroid cancer incidence Median follow-up of ~4.5 years Risk estimates comparable or lower than other glucose-lowering therapies Overall, current epidemiological evidence does not support a clinically meaningful increase in thyroid cancer risk in humans
L-carnitine reduces hospital admissions in patients with hepatic encephalopathy